|
Volumn 23, Issue 2-3, 2007, Pages 98-100
|
Lack of effect of oral selenite on p53 associated gene expression during TL01 therapy of psoriasis patients
|
Author keywords
Langerhans cells; Phototherapy; Sodium selenite; Sunburn cells; UV induced proteins
|
Indexed keywords
FAS ANTIGEN;
GUANOSINE;
PLACEBO;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN P53;
SODIUM SELENITE;
T6 ANTIGEN;
ADULT;
ARTICLE;
CELL COUNT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
FEMALE;
GENE EXPRESSION;
GENETIC CODE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LANGERHANS CELL;
MALE;
OUTCOME ASSESSMENT;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PROTEIN DETERMINATION;
PROTEIN EXPRESSION;
PROTEIN PHOSPHORYLATION;
PSORIASIS;
RADIATION INJURY;
RANDOMIZED CONTROLLED TRIAL;
SKIN BIOPSY;
SKIN CELL;
SKIN INJURY;
TREATMENT DURATION;
TUMOR SUPPRESSOR GENE;
ULTRAVIOLET A RADIATION;
WHOLE BODY RADIATION;
ADMINISTRATION, ORAL;
ADULT;
COMBINED MODALITY THERAPY;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
MALE;
MIDDLE AGED;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
SODIUM SELENITE;
TREATMENT OUTCOME;
TUMOR SUPPRESSOR PROTEIN P53;
ULTRAVIOLET RAYS;
ULTRAVIOLET THERAPY;
|
EID: 34249796970
PISSN: 09054383
EISSN: 16000781
Source Type: Journal
DOI: 10.1111/j.1600-0781.2007.00277.x Document Type: Article |
Times cited : (7)
|
References (5)
|